Taaleri invests in Nordtreat, a company producing environmentally friendly and non-toxic fire retardants
TAALERI PLC PRESS RELEASE 9 MARCH 2022 AT 9:15 (EET)
Taaleri invests in Nordtreat, a company producing environmentally friendly and non-toxic fire retardants
Taaleri invests EUR 1.0 million in Nordtreat, a Finnish company producing environmentally friendly and non-toxic fire retardants. Nordtreat raised a total of EUR 4 million in its latest financing round, which will help the company accelerate its international growth, expand its product portfolio and develop its production at the company's plant in Vantaa.
Founded in 2015, Nordtreat manufactures e.g. fire retardant chemicals based on non-toxic bio-based acids for building materials made from renewable raw materials. The company has developed and commercialized fire retardants, especially for wood construction. The products are based on the company's patented fire protection technology. Nordtreat's products replace traditional fire retardants that contain compounds that are harmful to humans and the environment, such as boric acid, formaldehyde, and ammonia.
The investment in Nordtreat opens up investment opportunities for the Taaleri Bioindustry I fund, which is in the fundraising phase. The fund was launched last December and was one of Finland's first private equity funds to be classified as dark green, i.e. funds under Article 9 of the EU Sustainable Finance Disclosure Regulation. The fund only makes sustainable investments in projects that, for example, contribute substantially to climate change mitigation.
“We are very pleased that Taaleri was given the opportunity to participate in Nordtreat’s private placement. The company is set to be one of the first investment targets for our bioindustry fund, and we see great potential for its international growth. We believe that the demand for sustainable fire retardants will increase in the international construction product industry as the sustainability requirements of developers become stricter,” says Tero Saarno, Director of Taaleri Bioindustry.
“We are very pleased with Taaleri's decision to support our growth. The placement enables sustainable investments that many traditional investors are not yet ready for. We believe that Taaleri Bioindustry's expertise will be of considerable benefit to us both in future production plant investments and in terms of sustainability issues,” says Aki Borgentrop, CEO of Nordtreat.
Taaleri Group’s vision is to be a Nordic forerunner in alternative investments focusing on sustainability. Through our private equity funds, we create, for example, wind and solar power and affordable rental homes.
For further information, please contact:
Tero Saarno, Director, Taaleri Bioindustry, +358 50 373 1923, tero.saarno@taaleri.com
Aki Borgentrop, CEO, Nordtreat, +358 400 366 801
Taaleri in brief
Taaleri is a Nordic investment and asset manager with an emphasis on renewable energy and other alternative investments. We channel capital towards economically profitable undertakings that have a lasting positive impact on the environment and society. We are a signatory of the UN Principles for Responsible Investment (UNPRI) since 2010, and we joined the Net Zero Asset Managers initiative in 2021. Taaleri’s vision is to be a Nordic forerunner in alternative investments focusing on sustainability.
Taaleri has two business segments: Private Asset Management and Strategic Investments. Private Asset Management consists of renewable energy, real estate, bioindustry and infrastructure businesses. The Strategic Investments segment includes Garantia Insurance Company Ltd.
Taaleri has EUR 2.2 bn of assets under management in its private equity funds and co-investments. The company has approximately 120 employees. Taaleri Plc is listed on Nasdaq Helsinki.
Nordtreat in brief
Founded in 2015, Nordtreat is a growth company in chemical industry specializing in the manufacture of non-toxic fire retardants. Nordtreat's patented technology is used in the fire protection of building materials made from renewable materials, especially in the construction of public and apartment buildings.
The company employs a total of 22 people in Finland, France, Germany, and Poland, and operates its own plant in Vantaa.
Siri Markula, Head of Communications and IR, tel. +358 40 743 2177, siri.markula@taaleri.com
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
About Taaleri Bioteollisuus
Subscribe to releases from Taaleri Bioteollisuus
Subscribe to all the latest releases from Taaleri Bioteollisuus by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Taaleri Bioteollisuus
Taaleri Bioteollisuus sijoittaa kierrätysbetonin jalostusyhtiö C2CA:han13.11.2024 09:07:00 EET | Tiedote
TAALERI BIOTEOLLISUUS LEHDISTÖTIEDOTE 13.11.2024 KLO 9:07 Taaleri Bioteollisuus sijoittaa kierrätysbetonin jalostusyhtiö C2CA:han Taaleri Bioteollisuus I -rahasto sijoittaa alankomaalaiseen C2CA Technology B.V. -yhtiöön, joka on kierrätysbetonin jalostaja. Investointi mahdollistaa kaupallisen kokoluokan tuotantolaitoksen rakentamisen Alankomaiden Rotterdamiin. Valmistuessaan tuotantolaitos käsittelee 150 000 tonnia purkubetonia vuodessa. C2CA on kehittänyt menetelmän, joka mahdollistaa purkubetonin käytön osana uuden betonin valmistusta. Innovatiivisen prosessin ansiosta sellaista betonia, joka tavanomaisessa käytössä on tullut elinkaarensa loppuun, pystytäänkin jatkojalostamaan. Mekaanisen prosessin ja lämmön avulla purkubetoni voidaan erotella peruskomponenteiksi, kuten kiviainekseksi, hiekaksi ja sementiksi. Lisäksi prosessin avulla sementtijae jatkojalostetaan, mikä mahdollistaa kierrätysjakeen käytön uuden betonin valmistuksessa. C2CA:n kierrätettyjä materiaaleja on hyödynnetty ku
Taaleri Bioindustry invests in C2CA, a company upcycling waste concrete13.11.2024 09:07:00 EET | Press release
TAALERI BIOINDUSTRY PRESS RELEASE 13 NOVEMBER 2024 AT 9:07 (EET) Taaleri Bioindustry invests in C2CA, a company upcycling waste concrete Taaleri Bioindustry Fund I is investing in C2CA Technology B.V., a Duch company and the technological leader in waste concrete upcycling. The investment will enable the construction of a full-scale commercial production facility in Rotterdam, in the Netherlands. The factory will process approximately 150,000 tonnes of waste concrete annually. C2CA has developed a process that allows upcycling of end-of-life concrete into drop-in materials for use in new concrete. The innovative process enables the effective separation of the individual components of end-of-life concrete (aggregate, sand and cement paste) through the combination of mechanical and thermal processes. C2CA's upcycled materials have been used in six reference construction projects under the Dutch Climate Envelope initiative, showcasing their quality and performance in real-world applicatio
Taalerin bioteollisuusrahasto sijoittaa sieniproteiinia valmistavaan Eniferiin23.5.2024 08:45:00 EEST | Tiedote
TAALERI BIOTEOLLISUUS LEHDISTÖTIEDOTE 23.5.2024 KLO 8.45 Taalerin bioteollisuusrahasto sijoittaa sieniproteiinia valmistavaan Eniferiin Taalerin bioteollisuuteen keskittyvä Bioteollisuus I -rahasto sijoittaa suomalaiseen sieni- eli mykoproteiinia valmistavaan Eniferiin. Sijoitus mahdollistaa uuden tuotantolaitoksen rakentamisen Kantvikiin Kirkkonummelle. Enifer perustettiin vuonna 2020 patentoidun PEKILO®-teknologian jatkokehittämistä ja kaupallistamista varten. Mykoproteiinin valmistuksessa hyödynnetään fermentointiprosessia, joka kehitettiin Suomessa alun perin 1970-luvulla. Nykyinen valmistustapa muistuttaa oluen tai soijan fermentointiprosessia. Eniferin mykoproteiini on kestävä vaihtoehto eläin- ja kasviproteiineille. Vaihtoehtoinen proteiininlähde edesauttaa biodiversiteetin säilymistä, sillä tuotanto ei vaadi maankäyttöä ja lisää sitä epäsuorasti vain vähän. Enifernin mykoproteiinilla on matala hiili- ja vesijalanjälki verrattuna eläin- ja kasviproteiineihin. PEKILO®-mykoproteii
Taaleri’s bioindustry fund invests in Enifer, a company producing mycoprotein23.5.2024 08:45:00 EEST | Press release
TAALERI BIOINDUSTRY PRESS RELEASE 23 MAY 2024 AT 8:45 (EEST) Taaleri’s bioindustry fund invests in Enifer, a company producing mycoprotein Taaleri Bioindustry Fund I invests in Enifer, a Finnish company producing fungi-based mycoprotein. Investment enables Enifer to construct a new mycoprotein factory in Kantvik, Kirkkonummi, Finland. Enifer was founded in 2020 to develop and commercialize the proprietary PEKILO® technology further. Mycoprotein is produced by cultivating a specific species of fungus in a fermentation process that is not too distinct from brewing beer or making soy sauce. The PEKILO® fermentation process was originally developed in Finland in the 1970s and used by the forest industry. Mycoprotein is a sustainable alternative to animal and some soy proteins. This alternative protein has a significant positive contribution to biodiversity because the production process does not require direct land use as many other plant and animal proteins do. The production of mycoprote
Taaleri’s bioindustry fund invests in Nordic Bioproducts Group, a company producing cellulose-based materials with a high processing value30.3.2023 09:15:00 EEST | Press release
TAALERI BIOINDUSTRY PRESS RELEASE 30 MARCH 2023 AT 9:15 (EEST) Taaleri’s bioindustry fund invests in Nordic Bioproducts Group, a company producing cellulose-based materials with a high processing value Taaleri’s bioindustry fund invests in Nordic Bioproducts Group, a Finnish company producing cellulose-based materials with a high processing value. The purpose of the investment is to strengthen Nordic Bioproducts Groups’s (NBG) growth and expansion. Nordic Bioproducts Group was founded in 2019 to develop new biomaterials based on the patented AaltoCell technology. The cellulose hybrids developed and manufactured by NBG are processed from Finnish forest fibres and cellulose-containing industrial and agricultural side and waste streams. The company aims to bring to the market environmentally more sustainable and low-emissions alternatives to fossil raw materials and harmful chemicals. For example, in the textile industry, pulp-based fibres can replace cotton and artificial fibres, and in
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom